Analyst Graham Parry of Bank of America Securities maintained a Buy rating on Sanofi (SNYNF – Research Report), retaining the price ...

J.P. Morgan analyst Richard Vosser maintained a Hold rating on Sanofi (SNYNF – Research Report) today and set a price target of €100.00.

In all, the partners plan to provide enough supply to cover every eligible infant in the U.S. Sanofi has begun shipping the ...

Adult Vaccine Market Adult Vaccine Market Dublin, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The "Adult Vaccine Market Report, ...

An ambitious project that was hatched during the coronavirus pandemic has hit a key milestone as Sanofi has completed construction of Modulus, a vaccine and biological medicine plant that can be ...

Heat stroke is an emergency! Call 9 1 1. && Once upon a time, Sanofi Pasteur in Swiftwater, Monroe County, was the principal vaccine brand of Sanofi, the Paris-based international pharmaceutical ...

Panacea Biotec shares touched a new 52-week high on Tuesday after Sanofi Healthcare India agreed to not commercially produce its fully liquid hexavalent vaccine Shan6 in India, directly or ...

A French pharmaceutical company has been trying to stop a proposed condo development near its Toronto campus by arguing that ...

Panacea Biotec has resolved a patent infringement lawsuit with Sanofi Healthcare concerning its EasySix hexavalent vaccine. Under the settlement, Sanofi will refrain from launching its Shan6 ...

Novavax has secured a transformative partnership with Sanofi, which includes $1.2 billion in potential payments and critical commercial support. The company’s COVID-19 vaccine targets the JN.

Sanofi said an oral treatment for multiple sclerosis, tolebrutinib, met its key goal in a Phase 3 study, potentially clearing the way for regulatory approval, although in two other studies ...

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The "Adult Vaccine market Report, Forecast by Disease, Countries and Company Analysis, 2024-2032" report has been added ...